precision medicine

Jackie Rice, VP and chief information officer at Frederick Health, says adding pharmacogenetic data to the health system's EHR enables alerts that advise clinicians on how a patient’s genes can affect drug response.

Genetic therapy is effective but can cost millions of dollars. Boro Dropulić, executive director of Caring Cross, says technology innovations and partnerships with hospitals and governments can help lower costs and increase accessibility.

The funding round brings the company's total raise to $1.86 billion since it launched in 2018.

The olivia app will allow patients to aggregate their health data in a central location.

The aim of the partnership is to allow healthcare providers to offer precision medicine support tools.   

The tech aims to deliver AI-driven drug response prediction to human oncology.  

The Hennessy Institute for Cancer Prevention and Applied Molecular Medicine will utilize CancerIQ’s AI platform for personalized risk assessments and advanced early detection.

The multiple sclerosis-focused company will use the funds to speed up the company's commercialization efforts.

The partners will develop a database for academics and biopharma researchers to acquire insights to help advance cancer-focused research.

At HIMSS23, panelists discussed how genomics could improve patient care and the challenges to implementing genetic testing programs.